IPP Bureau

Croda secures financial support from UK Government for expansion of lipid systems manufacturing facility
Croda secures financial support from UK Government for expansion of lipid systems manufacturing facility

By IPP Bureau - April 04, 2022

The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines

Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment
Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment

By IPP Bureau - April 03, 2022

Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024

WHO suspends supply of Covaxin under Covax facility
WHO suspends supply of Covaxin under Covax facility

By IPP Bureau - April 03, 2022

WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility

JBCPL buys Azmarda trademark for India at Rs 246 crore
JBCPL buys Azmarda trademark for India at Rs 246 crore

By IPP Bureau - April 03, 2022

The brand Azmarda fits well with JBCPL's overall strategy of strengthening its presence in the cardiology segment in India.

Blue Star opens medical diagnostic equipment refurbishment facility in Maharashtra
Blue Star opens medical diagnostic equipment refurbishment facility in Maharashtra

By IPP Bureau - April 03, 2022

Through this new set-up, the company intends to make available, affordable high-quality medical diagnostic imaging equipment across Tier 2, 3, and 4 towns in India

Panacea Biotec appoints NK Juneja as additional director
Panacea Biotec appoints NK Juneja as additional director

By IPP Bureau - April 03, 2022

He has done his Masters in Pharmacy (M. Pharm) and Post Graduate Diploma in Personnel Management & Industrial Relations

Jubilant Pharmova to acquire stake in Greencure
Jubilant Pharmova to acquire stake in Greencure

By IPP Bureau - April 03, 2022

There is also a strong synergy between Jubilant and Greencure with respect to OTC portfolio which can be explored for R&D, online acceleration and offline distribution

Jenburkt Wellness launches D2C brand Zixa strong
Jenburkt Wellness launches D2C brand Zixa strong

By IPP Bureau - April 03, 2022

The organization has introduced an advanced FlashMicelle technology which is a combination of ultra-rapid mixing techniques, and a uniquely powerful approach to modify the structure of oil-based formulations to improve their therapeutic efficacy substantially

Doctors at Yashoda Hospitals perform Cone Beam CT guided lung biopsy
Doctors at Yashoda Hospitals perform Cone Beam CT guided lung biopsy

By IPP Bureau - April 03, 2022

This state-of-art technology will help pulmonologists to diagnose lung cancer in the very early stages helping the patient get an early surgical resection

USFDA approves Yescarta as first CAR T-cell therapy for Lymphoma
USFDA approves Yescarta as first CAR T-cell therapy for Lymphoma

By IPP Bureau - April 03, 2022

Yescarta is First CAR T-cell therapy to receive NCCN treatment guideline category 1 recommendation --

Dr. Reddy's and MediCane Health launch medical cannabis in Germany
Dr. Reddy's and MediCane Health launch medical cannabis in Germany

By IPP Bureau - April 03, 2022

The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021

WHO selects Biological E for mRNA tech transfer
WHO selects Biological E for mRNA tech transfer

By IPP Bureau - April 03, 2022

Primarily set up to address the Covid-19 emergency, the WHO technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities such as malaria, HIV and cancer

New data indicate molnupiravir eliminates Covid-19 rapidly
New data indicate molnupiravir eliminates Covid-19 rapidly

By IPP Bureau - April 03, 2022

Among patients with infectious virus at baseline, no patients who received Lagevrio had infectious virus at days 3, 5 or 10

Lonza Joins International Pharmaceutical Aerosol Consortium
Lonza Joins International Pharmaceutical Aerosol Consortium

By IPP Bureau - April 01, 2022

Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies

Bayer to set up 27 telemedicine centres across eight states
Bayer to set up 27 telemedicine centres across eight states

By IPP Bureau - April 01, 2022

Bayer will be setting up 27 telemedicine centres in 12 districts across 8 states with implementing partners Telerad RxDx and Piramal Swasthya

Latest Stories

Interviews

Packaging